000			01913 a2200469 4500
005			20250517023101.0
264		0	_c20160120
008			201601s 0 0 eng d
022			_a1872-6240
024	7		_a10.1016/j.brainres.2015.03.022 _2doi
040			_aNLM _beng _cNLM
100	1		_aYang, Li
245	0	0	_aIn vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment. _h[electronic resource]
260			_bBrain research _cJun 2015
300			_a1-11 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer _xchemistry
650	0	4	_aAnalgesics, Opioid _xchemistry
650	0	4	_aBrain Edema _xdrug therapy
650	0	4	_aBrain Infarction _xdrug therapy
650	0	4	_aBrain Ischemia _xdrug therapy
650	0	4	_aCells, Cultured
650	0	4	_aEnkephalin, Ala(2)-MePhe(4)-Gly(5)- _xchemistry
650	0	4	_aEnkephalin, D-Penicillamine (2,5)- _xchemistry
650	0	4	_aEnkephalins _xchemistry
650	0	4	_aGlutamic Acid _xtoxicity
650	0	4	_aIschemia _xdrug therapy
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuroprotective Agents _xchemistry
650	0	4	_aReceptors, Opioid, delta _xagonists
650	0	4	_aReceptors, Opioid, kappa _xagonists
650	0	4	_aReceptors, Opioid, mu _xagonists
650	0	4	_aReperfusion Injury _xdrug therapy
650	0	4	_aSeverity of Illness Index
650	0	4	_aStroke _xdrug therapy
700	1		_aIslam, Mohammad R
700	1		_aKaramyan, Vardan T
700	1		_aAbbruscato, Thomas J
773	0		_tBrain research _gvol. 1609 _gp. 1-11
856	4	0	_uhttps://doi.org/10.1016/j.brainres.2015.03.022 _zAvailable from publisher's website
999			_c24734575 _d24734575